Birth Asphyxia complications impact a very large number of Newborns every year resulting in high morbidity & mortality. Currently there is no effective means to diagnose the severity of Asphyxia to enable initiation of early treatment. This delay in diagnosis results in grievous damage to the Newborn’s brain.
Illuminatus can change that. The first of its kind, Illuminatus uses a combination of brain electrical activity and brain tissue oxygenation measurements to assess the impact and localization of the Asphyxia event. This will help determine the extent and severity of the brain damage and aid in quicker and effective treatment.